These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17348703)

  • 21. Cyclophilin 40: an Hsp90-cochaperone associated with apo-steroid receptors.
    Ratajczak T; Ward BK; Cluning C; Allan RK
    Int J Biochem Cell Biol; 2009; 41(8-9):1652-5. PubMed ID: 19433306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel HSP90 chaperone complex regulates intracellular vesicle transport.
    Lotz GP; Brychzy A; Heinz S; Obermann WM
    J Cell Sci; 2008 Mar; 121(Pt 5):717-23. PubMed ID: 18270269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
    Gray PJ; Stevenson MA; Calderwood SK
    Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Grp on the Hsp90 mechanism.
    Richter K; Reinstein J; Buchner J
    Mol Cell; 2007 Oct; 28(2):177-9. PubMed ID: 17964255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular chaperone Hsp90 is a component of the cap-binding complex and interacts with the translational repressor Cup during Drosophila oogenesis.
    Pisa V; Cozzolino M; Gargiulo S; Ottone C; Piccioni F; Monti M; Gigliotti S; Talamo F; Graziani F; Pucci P; Verrotti AC
    Gene; 2009 Mar; 432(1-2):67-74. PubMed ID: 19101615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity.
    Avila C; Kornilayev BA; Blagg BS
    Bioorg Med Chem; 2006 Feb; 14(4):1134-42. PubMed ID: 16213144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress.
    Workman P; Burrows F; Neckers L; Rosen N
    Ann N Y Acad Sci; 2007 Oct; 1113():202-16. PubMed ID: 17513464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90: breaking the symmetry.
    Mayer MP; Le Breton L
    Mol Cell; 2015 Apr; 58(1):8-20. PubMed ID: 25839432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive study on the immunological reactivity of the Hsp90 molecular chaperone.
    Kawano T; Kobayakawa T; Fukuma Y; Yukitake H; Kikuchi Y; Shoji M; Nakayama K; Mizuno A; Takagi T; Nemoto TK
    J Biochem; 2004 Nov; 136(5):711-22. PubMed ID: 15632312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the Hsp90 system.
    Sima S; Richter K
    Biochim Biophys Acta Mol Cell Res; 2018 Jun; 1865(6):889-897. PubMed ID: 29563055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsp90's secrets unfold: new insights from structural and functional studies.
    Caplan AJ
    Trends Cell Biol; 1999 Jul; 9(7):262-8. PubMed ID: 10370241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hsp90: twist and fold.
    Richter K; Buchner J
    Cell; 2006 Oct; 127(2):251-3. PubMed ID: 17055424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsp90 at the crossroads of genetics and epigenetics.
    Wong KS; Houry WA
    Cell Res; 2006 Sep; 16(9):742-9. PubMed ID: 16940964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp90--from signal transduction to cell transformation.
    Brown MA; Zhu L; Schmidt C; Tucker PW
    Biochem Biophys Res Commun; 2007 Nov; 363(2):241-6. PubMed ID: 17826744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No stress--Hsp90 and signal transduction in Leishmania.
    Hombach A; Clos J
    Parasitology; 2014 Aug; 141(9):1156-66. PubMed ID: 24703183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.
    Citri A; Gan J; Mosesson Y; Vereb G; Szollosi J; Yarden Y
    EMBO Rep; 2004 Dec; 5(12):1165-70. PubMed ID: 15568014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsp90 recognizes a common surface on client kinases.
    Citri A; Harari D; Shohat G; Ramakrishnan P; Gan J; Lavi S; Eisenstein M; Kimchi A; Wallach D; Pietrokovski S; Yarden Y
    J Biol Chem; 2006 May; 281(20):14361-9. PubMed ID: 16551624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches for defining the Hsp90-dependent proteome.
    Hartson SD; Matts RL
    Biochim Biophys Acta; 2012 Mar; 1823(3):656-67. PubMed ID: 21906632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain.
    Tsutsumi S; Mollapour M; Graf C; Lee CT; Scroggins BT; Xu W; Haslerova L; Hessling M; Konstantinova AA; Trepel JB; Panaretou B; Buchner J; Mayer MP; Prodromou C; Neckers L
    Nat Struct Mol Biol; 2009 Nov; 16(11):1141-7. PubMed ID: 19838189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hsp90 in Cancer: Transcriptional Roles in the Nucleus.
    Calderwood SK; Neckers L
    Adv Cancer Res; 2016; 129():89-106. PubMed ID: 26916002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.